BioNTech and US coronavirus jab rival Moderna ... A researcher at Moderna HQ in Cambridge, Massachusetts. The company is seeking ways to expand mRNA vaccines from its groundbreaking Coronavirus ...

This did not stymie Pfizer's desire to move its HQ out of the US ... a COVID-19 vaccine approved – via its collaboration with BioNTech – it feels like we're only on the cusp of seeing where ...

LOS ANGELES, CA - (NewMediaWire) - June 5, 2024 - HQ Global Education, Inc. (OTC: HQGE) announced today that its wholly owned operating subsidiary, Big M Entertainment Pictures, will collaborate ...

BioNTech SE Sponsored ADR (BNTX) shares soared 5.8% in the last trading session to close at $105. The move was backed by solid volume with far more shares changing hands than in a normal session.

UBS analyst Eliana Merle maintained a Hold rating on BioNTech SE (BNTX – Research Report) today and set a price target of $131.00. The company’s shares opened today at $121.40. According to ...

BioNTech SE (BNTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Robert Burns from H.C. Wainwright reiterated a Buy rating on the stock ...

Cognizant puts for sale its India HQ at Chennai, once serving as the operating base for its founders, in a move to consolidate operations in three other places IT major Cognizant has put for sale ...

mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...

A preemptive Israeli sortie took out thousands of Hezbollah rocket launcher barrels Sunday morning, including some believed to be aimed at the Mossad headquarters in central Israel, the military ...

(RTTNews) - Kuick Research announced the initiation of the first mRNA lung cancer vaccine trials globally with German biotech firm BioNTech SE's (BNTX) BNT116 as a significant breakthrough in ...

Along the way, Duality has entered into deals with BioNTech, BeiGene and Adcendo that could be worth more than $4 billion. Duality plans to take two bispecific ADCs and one autoimmune ADC into ...

Healthcare & Pharmaceuticalscategory US FDA puts partial clinical hold on BioNTech's early-stage study of cancer drug June 17, 2024 Reuters, the news and media division of Thomson Reuters, ...